Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1548 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Eisai To Introduce OTC Drug Travelmin 1

Eisai claimed that Travelmin 1 is a rapidly disintegrating motion sickness remedy for adults whose active ingredients, comprising an antihistaminic (meclizine hydrochloride) and an anticholinergic (scopolamine hydrobromide hydrate),

EpiCept Submits NDA For Ceplene

EpiCept said that Ceplene had received approval for this indication by the European Commission in October 2008 and is currently made available in the UK, Germany and Austria.